Review of COVID-19 tests remains top priority -acting U.S. FDA chief
The U.S. Food and Drug Administration is focused on reviewing at-home and other COVID-19 tests, particularly those that can be manufactured at scale, Acting FDA Commissioner Janet Woodcock said at a Senate hearing on Tuesday
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.